Showing results (301-310 of 324) with videos related to

Sort By:
Pageof 33
AI Zheng = Aizheng = Chinese Journal of Cancer|January 11, 2003
[Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality]Hui-qiang Huang, Wen-qi Jiang, Wei Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2025
Prognostic Significance of SOX9 and Its Combination With RAS and TP53 Mutations Following Colorectal Cancer Liver MetastasectomyJian-Li Duan, Lei Wen, Yan-Yu Cai, et al.
Cell Reports|June 7, 2023
Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal originsMiao-Zhen Qiu, Qingjian Chen, Dan-Yang Zheng, et al.
Cancer Cell|April 14, 2023
An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinomaYan-Xing Chen, Zi-Xian Wang, Ying Jin, et al.
Oncotarget|October 7, 2015
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot studyYu Hong Li, Miao Zhen Qiu, Jian Ming Xu, et al.
Oncotarget|April 7, 2016
Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment responseZhe-Zhen Li, Feng Wang, Zi-Chen Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 14, 2016
Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expressionDong-Liang Chen, Huai-Qiang Ju, Yun-Xin Lu, et al.
Annals of Translational Medicine|March 12, 2021
Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populationsHao-Cheng Lin, Qiong Shao, Jie-Ying Liang, et al.
Theranostics|March 7, 2018
Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox ModulationYun-Xin Lu, Qi-Nian Wu, Dong-Liang Chen, et al.
Theranostics|May 14, 2025
Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: ErratumYun-Xin Lu, Qi-Nian Wu, Dong-Liang Chen, et al.
Pageof 33